Nanoscale 12 , 25552568 (2020)
[2] In addition, similarly to pralmorelin (GHRP-2) and GHRP-6, it slightly and dose-dependently stimulates the release of prolactin, adrenocorticotropic hormone (ACTH), and cortisol in humans
First, clinical validation remains inadequate: although preclinical data highlight the promise of multimodal therapies (e.g., co-delivering urate-lowering agents and anti-inflammatory drugs), robust clinical evidence is lacking
More A big thank you to Tanesha, my therapist, who is very bubbly and informative
The vast majority of human clinical data for both Semax and Selank comes from Eastern Europe (primarily Russia)